Biomedical Engineering Reference
In-Depth Information
12. Rajagopalan H, Bardelli A, Lengauer C,
et al.
Tumorigenesis: RAF/
RAS oncogenes and mismatch-repair status.
Nature
2002; 418: 934.
doi:10.1038/418934a.
13. Nosho K, Irahara N, Shima K,
Comprehensive biostatistical
analysis of CpG island methylator phenotype in colorectal cancer using
a large population-based sample.
et al.
2008; 3: e3698. Published
on 20081112. doi:10.1371/journal.pone.0003698.
14. Nosho K, Kawasaki T, Ohnishi M,
PLoS One
PIK3CA mutation in colorectal
cancer: relationship with genetic and epigenetic alterations.
et al.
Neoplasia
2008; 10: 534-541.
15. Brink M, de Goeij AF, Weijenberg MP,
K-ras oncogene mutations
in sporadic colorectal cancer in The Netherlands Cohort Study.
Carcinogenesis
et al.
2003; 24: 703-710.
16. de Vogel S, Weijenberg MP, Herman JG,
MGMT and MLH1 promoter
methylation versus APC, KRAS and BRAF gene mutations in colorectal
cancer: indications for distinct pathways and sequence of events.
et al.
Ann
2009; 20: 1216-1222. Published on 20090122. doi:10.1093/
annonc/mdn782.
17. Bamford S, Dawson E, Forbes S,
Oncol
The COSMIC (Catalogue of
Somatic Mutations in Cancer) database and website.
et al.
Br J Cancer
2004;
91: 355-358. doi:10.1038/sj.bjc.6601894.
18. Barault L, Veyrie N, Jooste V,
Mutations in the RAS-MAPK, PI(3)
K (phosphatidylinositol-3-OH kinase) signaling network correlate
with poor survival in a population-based series of colon cancers.
et al.
Int J
2008; 122: 2255-2259. doi:10.1002/ijc.23388.
19. Vetter IR, Wittinghofer A. The guanine nucleotide-binding switch
in three dimensions.
Cancer
Science
2001; 294: 1299-1304. doi:10.1126/
science.1062023.
20. Bos JL. Ras Oncogenes in Human Cancer: a Review.
Cancer Res
1989;
49: 4682-4689.
21. Lea IA, Jackson MA, Dunnick JK. Genetic pathways to colorectal cancer.
Mutat Res
2009; 670: 96-98. Published on 20090701. doi:10.1016/j.
mrfmmm.2009.06.011.
22. Wan PT, Garnett MJ, Roe SM,
Mechanism of activation of the RAF-
ERK signaling pathway by oncogenic mutations of B-RAF.
et al.
Cell
2004;
116: 855-867.
23. Preto A, Figueiredo J, Velho S,
BRAF provides proliferation
and survival signals in MSI colorectal carcinoma cells displaying
BRAF(V600E) but not KRAS mutations.
et al.
J Pathol
2008; 214: 320-327.
doi:10.1002/path.2295.
